Adam Berg

6.5k total citations
9 papers, 163 citations indexed

About

Adam Berg is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Adam Berg has authored 9 papers receiving a total of 163 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Infectious Diseases. Recurrent topics in Adam Berg's work include Virus-based gene therapy research (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and CAR-T cell therapy research (3 papers). Adam Berg is often cited by papers focused on Virus-based gene therapy research (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and CAR-T cell therapy research (3 papers). Adam Berg collaborates with scholars based in United Kingdom, United States and Germany. Adam Berg's co-authors include Simon Guiraud, Arran Babbs, Sarah Squire, Kay E. Davies, Benjamin Edwards, Lee Moir, Matthew J. A. Wood, Alexander D. Douglas, Sofiya Fedosyuk and Thomas A. Bowden and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Human Molecular Genetics.

In The Last Decade

Adam Berg

9 papers receiving 158 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Berg United Kingdom 8 113 28 28 23 20 9 163
Marisol Romero‐Tejeda United States 8 132 1.2× 24 0.9× 24 0.9× 28 1.2× 6 0.3× 12 272
Tara L. Fernandez Australia 6 38 0.3× 10 0.4× 12 0.4× 30 1.3× 17 0.8× 8 166
Makoto Koizumi Japan 14 365 3.2× 22 0.8× 37 1.3× 26 1.1× 24 1.2× 36 438
Hidekazu Kuma Japan 5 101 0.9× 91 3.3× 48 1.7× 23 1.0× 22 1.1× 7 240
Zehua Zhou China 9 67 0.6× 13 0.5× 49 1.8× 45 2.0× 17 0.8× 19 198
Martina Donadoni United States 9 107 0.9× 19 0.7× 57 2.0× 59 2.6× 4 0.2× 16 212
Abdulsamie Patel Belgium 5 84 0.7× 26 0.9× 21 0.8× 3 0.1× 15 0.8× 7 139
Tony Tang Taiwan 8 43 0.4× 6 0.2× 10 0.4× 7 0.3× 4 0.2× 10 136
Kumitaa Theva Das Malaysia 5 114 1.0× 43 1.5× 13 0.5× 19 0.8× 4 0.2× 13 146
Christophe Georger France 5 82 0.7× 35 1.3× 15 0.5× 13 0.7× 5 125

Countries citing papers authored by Adam Berg

Since Specialization
Citations

This map shows the geographic impact of Adam Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Berg more than expected).

Fields of papers citing papers by Adam Berg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Berg. The network helps show where Adam Berg may publish in the future.

Co-authorship network of co-authors of Adam Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Berg. A scholar is included among the top collaborators of Adam Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Berg. Adam Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zhang, Cheng, Adam Berg, Carina C. D. Joe, Paul A. Dalby, & Alexander D. Douglas. (2023). Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration. npj Vaccines. 8(1). 85–85. 7 indexed citations
2.
Joe, Carina C. D., Rameswara R. Segireddy, Adam Berg, et al.. (2023). Accelerated and intensified manufacturing of an adenovirus‐vectored vaccine to enable rapid outbreak response. Biotechnology and Bioengineering. 121(1). 176–191. 8 indexed citations
3.
Fedosyuk, Sofiya, Gilles Augusto, Adam Berg, et al.. (2022). Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies. Cell Host & Microbe. 30(9). 1219–1230.e7. 25 indexed citations
4.
Berg, Adam, Daniel Wright, Anna Stedman, et al.. (2021). Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations. Vaccines. 9(11). 1249–1249. 13 indexed citations
5.
Berg, Adam, Adam A. Walters, Nicholas Hawkins, et al.. (2021). Characterisation of factors contributing to the performance of nonwoven fibrous matrices as substrates for adenovirus vectored vaccine stabilisation. Scientific Reports. 11(1). 20877–20877. 4 indexed citations
6.
Babbs, Arran, Adam Berg, Maria Chatzopoulou, et al.. (2020). 2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy. Journal of Medicinal Chemistry. 63(14). 7880–7891. 15 indexed citations
7.
Guiraud, Simon, Benjamin Edwards, Arran Babbs, et al.. (2019). The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy. Human Molecular Genetics. 28(13). 2189–2200. 34 indexed citations
8.
Guiraud, Simon, Benjamin Edwards, Sarah Squire, et al.. (2018). Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD. Human Molecular Genetics. 28(2). 307–319. 29 indexed citations
9.
Guiraud, Simon, Benjamin Edwards, Sarah Squire, et al.. (2017). Identification of serum protein biomarkers for utrophin based DMD therapy. Scientific Reports. 7(1). 43697–43697. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026